Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06328673
Title A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors D2M Biotherapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.